Algert Global’s Thermo Fisher Scientific TMO Stock Holding History

Algert Global’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,708	Closed	-$2.12M	–	1117
2021 Q3	$2.12M	Sell	3,708 -612	-14%	-$336K	0.28%	41
2021 Q2	$2.18M	Buy	4,320 +154	+4%	+$72.7K	0.73%	17
2021 Q1	$1.9M	Buy	4,166 +3,676	+750%	+$1.75M	0.61%	32
2020 Q4	$228K	Sell	490 -3,264	-87%	-$1.53M	0.07%	335
2020 Q3	$1.66M	Buy	+3,754	New	+$1.55M	0.53%	57
2020 Q2	–	Sell	-2,240	Closed	-$635K	–	505
2020 Q1	$635K	Sell	2,240 -4,326	-66%	-$1.36M	0.27%	139
2019 Q4	$2.13M	Sell	6,566 -2,147	-25%	-$651K	0.64%	40
2019 Q3	$2.54M	Hold	8,713	–	–	0.95%	16
2019 Q2	$2.56M	Buy	8,713 +6,005	+222%	+$1.65M	0.95%	16
2019 Q1	$741K	Buy	+2,708	New	+$674K	0.42%	82

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Algert Global's TMO Position: Q4 2021 in Review

Algert Global sold out of Thermo Fisher Scientific (TMO) in Q4 2021, closing a stake of 3,708 shares — an estimated $2.12M sold.

Algert Global first reported a position in TMO in Q1 2019 and held it in 10 quarters. The position peaked at $2.56M in Q2 2019. 2,342 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

Algert Global reported no remaining Thermo Fisher Scientific position as of Q4 2021 after selling out during the quarter.
Algert Global sold 3,708 Thermo Fisher Scientific shares in Q4 2021, an estimated $2.12M.
Algert Global first reported a position in Thermo Fisher Scientific in Q1 2019 and held it in 10 quarters.
Algert Global's Thermo Fisher Scientific position peaked at $2.56M in Q2 2019.
2,342 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Algert Global's 13F filing for Q4 2021, filed 14 Feb 2022.